ZSAN Zosano Pharma Corporation

Zosano Pharma Corporation (NASDAQ:ZSAN) announced today that Vikram Lamba, Chief Executive Officer, will provide a company overview at the Ladenburg Thalmann 2015 Healthcare Conference on September 29, 2015. The presentation will take place at 1:30 p.m. ET at the Sofitel Hotel in New York, New York.

A copy of the presentation can be accessed through the Zosano website at http://www.zosanopharma.com. Under the "Investors" tab, select the link to "Events & Presentations."

About Zosano Pharma

Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver drug formulations through the skin for the treatment of a variety of indications. Zosano's microneedle patch system offers rapid onset, consistent drug delivery, improved ease of use and room-temperature stability, benefits that the company believes often are unavailable using oral formulations or injections. Zosano's microneedle patch system has the potential to deliver numerous medications for a wide variety of indications in commercially attractive markets. It has been tested in more than 400 patients with over 30,000 patches successfully applied to humans in Phase 1 and Phase 2 clinical studies. Learn more at www.zosanopharma.com.

CONTACT: Zosano Contact:
         Vikram Lamba
         Chief Executive Officer
         510-745-1200
         
         Investor Contact:
         Patti Bank
         Westwicke Partners
         415-513-1284
         patti.bank@westwicke.com
         
         Media Contact:
         Jamie Lacey-Moreira
         PressComm PR, LLC
         410-299-3310
         jamielacey@presscommpr.com